Under dyslipidemic and inflammatory conditions such as hyperlipidemia, hypercholesterolemia, or obesity, caspase-1 activation leads to the upregulation of the inflammasome pathway, activated by elevated lipids or inflammatory mediators, such as DAMPs, in ECs [5,12]. This evidence concerns the gene CASP1 and Hypercholesterolemia.